ImportRefusal LogoImportRefusal

Shur-Gain

⚠️ Moderate Risk

FEI: 3003831329 • Montreal, QC • CANADA

FEI

FEI Number

3003831329

📍

Location

Montreal, QC

🇨🇦

Country

CANADA
🏢

Address

5 Commerce Place, , Montreal, QC, Canada

Moderate Risk

FDA Import Risk Assessment

39.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
4
Unique Violations
8/28/2003
Latest Refusal
3/31/2003
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
31.3×30%
Recency
0.0×20%
Frequency
60.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3083×

MFR INSAN

The article is subject to refusal of admission pursuant to section 801(a)(1) in that the article appears to have been manufactured, processed, or packed under insanitary conditions.

3362×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
8/28/2003
69AC34MONENSIN CATEGORY I, MEDICATED ANIMAL FEED
336INCONSPICU
New York District Office (NYK-DO)
8/21/2003
54YLY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
320LACKS FIRM
New York District Office (NYK-DO)
7/15/2003
69AC34MONENSIN CATEGORY I, MEDICATED ANIMAL FEED
308MFR INSAN
New York District Office (NYK-DO)
7/15/2003
70AY08MIXED GRAINS, FEEDS GROUND GRAINS ANIMAL
308MFR INSAN
New York District Office (NYK-DO)
7/15/2003
70AY08MIXED GRAINS, FEEDS GROUND GRAINS ANIMAL
308MFR INSAN
New York District Office (NYK-DO)
3/31/2003
69AC34MONENSIN CATEGORY I, MEDICATED ANIMAL FEED
336INCONSPICU
New York District Office (NYK-DO)

Frequently Asked Questions

What is Shur-Gain's FDA import refusal history?

Shur-Gain (FEI: 3003831329) has 6 FDA import refusal record(s) in our database, spanning from 3/31/2003 to 8/28/2003.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Shur-Gain's FEI number is 3003831329.

What types of violations has Shur-Gain received?

Shur-Gain has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Shur-Gain come from?

All FDA import refusal data for Shur-Gain is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.